Daiwa Securities Group’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $519K | Sell |
2,269
-835
| -27% | -$187K | ﹤0.01% | 899 |
|
|
2025
Q4 | $662K | Sell |
3,104
-584
| -16% | -$121K | ﹤0.01% | 844 |
|
|
2025
Q3 | $733K | Sell |
3,688
-49
| -1% | -$9.14K | ﹤0.01% | 813 |
|
|
2025
Q2 | $645K | Buy |
3,737
+1,488
| +66% | +$242K | ﹤0.01% | 812 |
|
|
2025
Q1 | $351K | Hold |
2,249
| – | – | ﹤0.01% | 881 |
|
|
2024
Q4 | $309K | Sell |
2,249
-68
| -3% | -$8.94K | ﹤0.01% | 909 |
|
|
2024
Q3 | $346K | Hold |
2,317
| – | – | ﹤0.01% | 905 |
|
|
2024
Q2 | $316K | Sell |
2,317
-162
| -7% | -$22K | ﹤0.01% | 907 |
|
|
2024
Q1 | $375K | Sell |
2,479
-151
| -6% | -$21.6K | ﹤0.01% | 881 |
|
|
2023
Q4 | $331K | Sell |
2,630
-124
| -5% | -$12.4K | ﹤0.01% | 886 |
|
|
2023
Q3 | $258K | Sell |
2,754
-108
| -4% | -$10.1K | ﹤0.01% | 922 |
|
|
2023
Q2 | $255K | Sell |
2,862
-97
| -3% | -$8.44K | ﹤0.01% | 917 |
|
|
2023
Q1 | $317K | Sell |
2,959
-92
| -3% | -$10.5K | ﹤0.01% | 880 |
|
|
2022
Q4 | $372K | Buy |
3,051
+29
| +1% | +$3.37K | ﹤0.01% | 860 |
|
|
2022
Q3 | $312K | Sell |
3,022
-76
| -2% | -$7.21K | ﹤0.01% | 884 |
|
|
2022
Q2 | $288K | Buy |
3,098
+409
| +15% | +$38.5K | ﹤0.01% | 918 |
|
|
2022
Q1 | $316K | Buy |
2,689
+368
| +16% | +$42.6K | ﹤0.01% | 931 |
|
|
2021
Q4 | $313K | Sell |
2,321
-302
| -12% | -$44.9K | ﹤0.01% | 935 |
|
|
2021
Q3 | $419K | Buy |
2,623
+425
| +19% | +$58.2K | ﹤0.01% | 877 |
|
|
2021
Q2 | $290K | Sell |
2,198
-314
| -13% | -$41.8K | ﹤0.01% | 902 |
|
|
2021
Q1 | $323K | Sell |
2,512
-90
| -3% | -$13.7K | ﹤0.01% | 882 |
|
|
2020
Q4 | $434K | Buy |
2,602
+2,338
| +886% | +$387K | ﹤0.01% | 789 |
|
|
2020
Q3 | $41K | Buy |
264
+5
| +2% | +$719 | ﹤0.01% | 948 |
|
|
2020
Q2 | $29K | Hold |
259
| – | – | ﹤0.01% | 1005 |
|
|
2020
Q1 | $29K | Hold |
259
| – | – | ﹤0.01% | 984 |
|
|
2019
Q4 | $36K | Sell |
259
-32
| -11% | -$3.56K | ﹤0.01% | 980 |
|
|
2019
Q3 | $28K | Buy |
291
+7
| +2% | +$781 | ﹤0.01% | 982 |
|
|
2019
Q2 | $33K | Buy |
284
+28
| +11% | +$3.35K | ﹤0.01% | 984 |
|
|
2019
Q1 | $30K | Sell |
256
-21
| -8% | -$1.84K | ﹤0.01% | 974 |
|
|
2018
Q4 | $17K | Buy |
277
+100
| +56% | +$6.28K | ﹤0.01% | 972 |
|
|
2018
Q3 | $13K | Hold |
177
| – | – | ﹤0.01% | 1017 |
|
|
2018
Q2 | $12K | Hold |
177
| – | – | ﹤0.01% | 1040 |
|
|
2018
Q1 | $12K | Buy |
+177
| New | +$9.95K | ﹤0.01% | 1016 |
|
Other funds holding ASND
RCM
ACA
